PE20142276A1 - Probiotico derivado del material no-viable para la prevencion y tratamiento de una infeccion - Google Patents

Probiotico derivado del material no-viable para la prevencion y tratamiento de una infeccion

Info

Publication number
PE20142276A1
PE20142276A1 PE2014001463A PE2014001463A PE20142276A1 PE 20142276 A1 PE20142276 A1 PE 20142276A1 PE 2014001463 A PE2014001463 A PE 2014001463A PE 2014001463 A PE2014001463 A PE 2014001463A PE 20142276 A1 PE20142276 A1 PE 20142276A1
Authority
PE
Peru
Prior art keywords
infection
treatment
prevention
viable material
probiotic
Prior art date
Application number
PE2014001463A
Other languages
English (en)
Inventor
Tol Eric A F Van
Gabriele Gross
Machtelt Braaksma
Karin M Overkamp
Eduard K Poels
Original Assignee
Mjn Us Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48045112&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20142276(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc
Publication of PE20142276A1 publication Critical patent/PE20142276A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pediatric Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

SE REFIERE A UNA COMPOSICION QUE COMPRENDE UN SOBRENADANTE DEL CULTIVO A PARTIR DE UNA FASE DEL CRECIMIENTO EXPONENCIAL TARDIO DE UN PROCESO DE CULTIVO DEL PROBIOTICO, QUE ES EL LACTOBACILLUS RHAMNOSUS GOLDIN GORBACH( LGG) Y EL PATOGENO EN LOTE. DICHA COMPOSICION ES UTIL EN EL TRATAMIENTO DE LA INFECCION POR UN PATOGENO COMO EL C. SAKAZAKII.
PE2014001463A 2012-03-23 2013-03-18 Probiotico derivado del material no-viable para la prevencion y tratamiento de una infeccion PE20142276A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12161083 2012-03-23

Publications (1)

Publication Number Publication Date
PE20142276A1 true PE20142276A1 (es) 2015-01-23

Family

ID=48045112

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2014001463A PE20142276A1 (es) 2012-03-23 2013-03-18 Probiotico derivado del material no-viable para la prevencion y tratamiento de una infeccion

Country Status (18)

Country Link
US (2) US20130251829A1 (es)
EP (1) EP2827725A1 (es)
CN (2) CN104219968A (es)
AR (1) AR090473A1 (es)
AU (1) AU2013235365B2 (es)
CA (1) CA2868109A1 (es)
CO (1) CO7151477A2 (es)
EC (1) ECSP14024082A (es)
HK (1) HK1204869A1 (es)
MX (1) MX360591B (es)
MY (1) MY169754A (es)
NZ (1) NZ627915A (es)
PE (1) PE20142276A1 (es)
PH (1) PH12014502112A1 (es)
RU (1) RU2014137188A (es)
SG (1) SG11201404378XA (es)
TW (1) TWI587864B (es)
WO (1) WO2013142403A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130251829A1 (en) * 2012-03-23 2013-09-26 Mead Johnson Nutrition Company Probiotic derived non-viable material for infection prevention and treatment
US20150157048A1 (en) 2013-12-11 2015-06-11 Mead Johnson Nutrition Company Nutritional compositions containing stearidonic acid and uses thereof
US20150290261A1 (en) * 2014-04-10 2015-10-15 Mead Johnson Nutrition Company Methods of use for probiotics and prebiotics
US20150305385A1 (en) 2014-04-25 2015-10-29 Mead Johnson Nutrition Company Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics
US20160029682A1 (en) 2014-08-01 2016-02-04 Mead Johnson Nutrition Company Hydrolyzed lactose-containing nutritional compositions and uses thereof
US20160095339A1 (en) 2014-10-01 2016-04-07 Mead Johnson Nutrition Company Nutritional composition for gastrointestinal environment to provide improved microbiome and metabolic profile
US9730969B2 (en) 2015-11-06 2017-08-15 Mead Johnson Nutrition Company Nutritional compositions for promoting gut barrier function and ameliorating visceral pain
US10034937B2 (en) 2015-12-04 2018-07-31 Mead Johnson Nutrition Company Synergistic nutritional compositions and uses thereof
US20180064739A1 (en) 2016-09-06 2018-03-08 Mead Johnson Nutrition Company Nutritional composition with human milk oligosaccharides and uses thereof
US20180103675A1 (en) 2016-10-14 2018-04-19 Mead Johnson Nutrition Company Personalized pediatric nutrition products comprising human milk oligosaccharides
US10980269B2 (en) 2016-12-12 2021-04-20 Mead Johnson Nutrition Company Protein hydrolysates and methods of making same
US20180160714A1 (en) 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
US20180161381A1 (en) * 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions and methods for reducing the occurrence or severity of viral infections, bacterial infections and viral and bacterial co-infections
US20180161292A1 (en) 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
US20180168215A1 (en) 2016-12-21 2018-06-21 Mead Johnson Nutrition Company Nutritional compositions containing inositol and uses thereof
US20180332881A1 (en) 2017-05-17 2018-11-22 Mead Johnson Nutrition Company Preterm infant formula containing butyrate and uses thereof
US20180333426A1 (en) 2017-05-17 2018-11-22 Mead Johnson Nutrition Company Nutritional composition with human milk oligosaccharides and uses thereof
CN107812018A (zh) * 2017-11-13 2018-03-20 浙江禾健生营养食品有限公司 一种灭活益生菌制品、制备方法及其应用
US20190208807A1 (en) 2018-01-05 2019-07-11 Mead Johnson Nutrition Company Nutritional compositions containing milk-derived peptides and uses thereof
GB2573538B (en) 2018-05-09 2023-01-04 Mjn Us Holdings Llc Pediatric nutritional compositions and methods for infants delivered by C-section
CN120513031A (zh) * 2022-12-14 2025-08-19 大型生物群系私人有限公司 含有益生菌上清液的组合物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
ES2157898T3 (es) 1991-01-24 2001-09-01 Martek Corp Aceites microbianos y usos de los mismos.
US5374567A (en) 1993-05-20 1994-12-20 The United States Of America As Represented By The Secretary Of The Navy Operational amplifier using bipolar junction transistors in silicon-on-sapphire
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
CN1164186C (zh) * 2001-04-29 2004-09-01 上海光明乳业股份有限公司 益菌奶及其制造方法
EP1384483A1 (en) 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
US20040208863A1 (en) * 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria
US7407652B2 (en) * 2005-06-03 2008-08-05 Aquatechnics Inc. Probiotic system for aquaculture
EP1951745A2 (en) * 2005-11-21 2008-08-06 Teagasc Dairy Products Research Centre Casein-derived antimicrobial peptides and lactobacillus strains that produce them
MX2009008875A (es) * 2007-02-28 2009-08-28 Mead Johnson Nutrition Co Producto que contiene probiotico inactivado para niños o infantes.
US20080254011A1 (en) * 2007-04-11 2008-10-16 Peter Rothschild Use of selected lactic acid bacteria for reducing atherosclerosis
RU2350648C1 (ru) * 2007-09-14 2009-03-27 Государственное научное учреждение Научно-исследовательский ветеринарный институт Нечерноземной зоны РФ Российской академии сельскохозяйственных наук Способ оценки антагонистической активности пробиотиков на основе лиофилизированной биомассы анаэробных бактерий по отношению к патогенным микобактериям
EP2130440A1 (en) 2008-06-06 2009-12-09 N.V. Nutricia Inhibiting E. sakazakii growth
US8137718B2 (en) * 2008-09-19 2012-03-20 Mead Johnson Nutrition Company Probiotic infant products
EP2295535A1 (en) * 2009-09-11 2011-03-16 Mead Johnson Nutrition Company Probiotic material
US20130251829A1 (en) * 2012-03-23 2013-09-26 Mead Johnson Nutrition Company Probiotic derived non-viable material for infection prevention and treatment
CN104531562B (zh) * 2014-12-09 2018-09-14 北京农学院 一种植物乳杆菌植物亚种及其抗单增李斯特菌细菌素的制备方法

Also Published As

Publication number Publication date
MX360591B (es) 2018-11-09
HK1204869A1 (en) 2015-12-11
CN104219968A (zh) 2014-12-17
AU2013235365A1 (en) 2014-08-21
WO2013142403A1 (en) 2013-09-26
TW201400124A (zh) 2014-01-01
MY169754A (en) 2019-05-15
US20130251829A1 (en) 2013-09-26
EP2827725A1 (en) 2015-01-28
NZ627915A (en) 2016-07-29
AR090473A1 (es) 2014-11-12
AU2013235365B2 (en) 2016-05-19
TWI587864B (zh) 2017-06-21
SG11201404378XA (en) 2014-08-28
CO7151477A2 (es) 2014-12-29
ECSP14024082A (es) 2015-09-30
CA2868109A1 (en) 2013-09-26
RU2014137188A (ru) 2016-05-20
PH12014502112A1 (en) 2014-12-10
US20170157185A1 (en) 2017-06-08
MX2014010150A (es) 2014-09-16
CN108714157A (zh) 2018-10-30

Similar Documents

Publication Publication Date Title
CO7151477A2 (es) Material no viable derivado de un probiótico para la prevención y el tratamiento de la infección
AR102657A1 (es) Composición para tratar telas
CR20170031A (es) Composiciones de portador-anticuerpo y métodos para realizarlas y utilizarlas
MX369211B (es) Fertilizante infundido con rizobacterias promotoras del crecimiento de las plantas.
PE20211663A1 (es) Bacterias lactobacillus con actividad antifungica
MX2016013950A (es) Metodo para producir l-aminoacidos utilizando una bacteria alcalifilica.
MX2016013247A (es) Composiciones y metodos para induccion de celulas th17.
UY34201A (es) Compuestos de azaindol y métodos para el tratamiento de vih.
MX384264B (es) Material anisotropico biocompuesto, implantes medicos que lo comprenden y metodos para el tratamiento del mismo
AR102658A1 (es) Composición para el tratamiento de telas
TW201613893A (en) Process for the preparation of 3-(3-chloro-1H-pyrazol-1-yl)pyridine
PL3178325T3 (pl) Zastosowanie szczepu bacillus methylotrophicus xt1 jako stymulatora wzrostu roślin i środka kontroli biologicznej oraz izolaty tego gatunku
MX2017003953A (es) Compuestos que contrarrestan el mal olor bajo, de cobertura-alta y metodos uso.
MX378313B (es) Produccion microbiana de dioles grasos.
BR112016023752A2 (pt) utilização de lactobacillus rhamnosus para promover a recuperação da diversidade da microbiota intestinal após disbiose
BR112015019294A2 (pt) fermentação anaeróbica de sementes de fruta
SG11201700792TA (en) Solution cultivation method for low potassium vegetable, low potassium vegetable and cultivation device
IN2014DN09841A (es)
PL3124599T3 (pl) Bakteria kwasu mlekowego należąca do rodzaju Weissella
CR20160144A (es) Sistema y procedimiento para la extracción de aceite de palma mediante fracturado, desgranado y esterilización dinámica del fruto fresco
MX2015015559A (es) Pivalato de 1-isopropoxi-1-oxopropan-2-ilo como ingrediente perfumante.
MX376887B (es) Separadores para implantes mamarios para el tratamiento de infecciones periprosteticas de los implantes mamarios.
SG11201701577WA (en) Lactic acid bacteria-containing composition
PE20141594A1 (es) Usos, metodos y composiciones biologicas del genero paecilomyces para el control, prevencion y erradicacion de fitoparasitos en cultivos de solanaceas
AR089034A1 (es) Lactobacillus brevis productor de reuterina

Legal Events

Date Code Title Description
FD Application declared void or lapsed